
China SXT Pharmaceuticals SXTC
$ 1.66
-5.68%
Annual report 2025
added 04-25-2026
China SXT Pharmaceuticals Total Inventories 2011-2026 | SXTC
Annual Total Inventories China SXT Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 828 K | 795 K | 531 K | 1.02 M | 860 K | 893 K | 1.01 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.02 M | 531 K | 847 K |
Quarterly Total Inventories China SXT Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 1.02 M | - | 837 K | - | 860 K | - | 867 K | - | 893 K | - | 846 K | - | 1.01 M | - | - | - | 1.27 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.27 M | 837 K | 949 K |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Exelixis
EXEL
|
21.7 M | $ 46.21 | -5.11 % | $ 12.5 B | ||
|
Fortress Biotech
FBIO
|
9.62 M | $ 2.4 | -5.88 % | $ 67 M | ||
|
Heron Therapeutics
HRTX
|
92.7 M | $ 1.24 | -5.34 % | $ 207 M | ||
|
Ionis Pharmaceuticals
IONS
|
10 M | $ 76.02 | -1.08 % | $ 12.2 B | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
14.1 M | $ 210.33 | -9.55 % | $ 3.85 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
91.7 M | $ 22.57 | 5.05 % | $ 3.74 B | ||
|
Mirum Pharmaceuticals
MIRM
|
24.9 M | $ 102.93 | -6.5 % | $ 5.17 B | ||
|
MannKind Corporation
MNKD
|
35.3 M | $ 3.55 | -0.28 % | $ 1.09 B | ||
|
Esperion Therapeutics
ESPR
|
105 M | $ 3.14 | -0.32 % | $ 653 M | ||
|
Albireo Pharma
ALBO
|
194 K | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 20.66 | -14.52 % | $ 2.63 B |